Fincanna Capital Corp
CNSX:CALI.X
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fincanna Capital Corp
CNSX:CALI.X
|
CA |
|
T
|
Twilio Inc
SWB:TWH
|
US |
|
RXO Inc
F:N9Q
|
US |
|
Globalfoundries Inc
NASDAQ:GFS
|
US |
|
G
|
Graincorp Ltd
F:G3C
|
AU |
|
Hong Kong and China Gas Co Ltd
F:HCGS
|
HK |
|
Hyundai Motor Co
F:HYU
|
KR |
|
F
|
Fresenius SE & Co KGaA
OTC:FSNUF
|
DE |
|
B
|
Becton Dickinson and Co
XBER:BOX
|
US |
|
A
|
Alnylam Pharmaceuticals Inc
SWB:DUL
|
US |
|
Rexford Industrial Realty Inc
F:3I0
|
US |
|
V
|
Vale SA
SWB:CVLC
|
BR |
|
Arcadis NV
OTC:ARCVF
|
NL |
|
Advantage Solutions Inc
NASDAQ:ADV
|
US |
|
O
|
Omnicom Group Inc
SWB:OCN
|
US |
|
I
|
Incyte Corp
DUS:ICY
|
US |
Bankruptcy Probability
Fincanna Capital Corp's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Fincanna Capital Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
F
|
Fincanna Capital Corp
CNSX:CALI
|
338.1k CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
560.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
298.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
225.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
265.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
314.4B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Fincanna Capital Corp's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Fincanna Capital Corp has no debt.
You can find a full breakdown on its Balance Sheet.
